SEC Form 4 · accession 0001209191-15-086996
HERON THERAPEUTICS, INC. /DE/ · HRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Rosen
Officer — President · Director
Period of report
Dec 22, 2015
Accepted (ET)
Dec 24, 2015 · 12:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000818033
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 2,640 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $29.41 | Dec 22, 2015 | A | 250,000 | A | — | Dec 22, 2025 | Common Stock | 250,000 | 250,000 | D |
Explanation of responses
- F1Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2013 at a purchase price of $6.12 per share.
- F2The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant.